Clinical trial / 2012
Weaning to bovine insulin-free cow's milk formula reduced the cumulative incidence of diabetes autoantibodies by age 3 in genetically at-risk infants.
The FINDIA pilot trial tested whether weaning infants genetically susceptible to type 1 diabetes to a bovine insulin-free cow's milk formula (FINDIA formula), a whey-based hydrolyzed formula (WHF), or ordinary cow's milk formula (CMF) for the first 6 months reduced beta-cell autoimmunity. In the intention-to-treat analysis, 2.6% in the FINDIA group, 4.9% in the WHF group, and 6.3% in the CMF group were positive for at least 1 autoantibody by age 3 years. Compared to CMF, the odds ratio was 0.39 (95% CI, 0.17-0.91) for the FINDIA formula and 0.75 (95% CI, 0.37-1.54) for WHF. In the treatment-received analysis, the odds ratios were 0.23 (95% CI, 0.08-0.69) for FINDIA formula and 0.81 (95% CI, 0.37-1.76) for WHF.
- Study type
- Randomized, double-blind pilot trial
- Who was studied
- 1113 infants with HLA-conferred susceptibility to type 1 diabetes
- What was measured
- Beta-cell autoimmunity (autoantibody positivity) monitored up to age 3 years
THE PAPER
Removal of Bovine Insulin From Cow's Milk Formula and Early Initiation of Beta-Cell Autoimmunity in the FINDIA Pilot Study.
Vaarala O, Ilonen J, Ruohtula T, Pesola J, Virtanen SM, Härkönen T, Koski M, Kallioinen H, Tossavainen O, Poussa T, Järvenpää AL, Komulainen J, Lounamaa R, Akerblom HK, Knip M. Arch Pediatr Adolesc Med, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.